Search
for
Sort by
Research 781–810 of 1000+
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Nutrition and the deleterious side effects of nutritional supplements
- Contraceptive implant use among inner city teens
- Hair Loss in Systemic Disease
- Topical Minoxidil
- Human pollution exposure correlates with accelerated ultrastructural degradation of hair fibers
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Pediatric Psychocutaneous Disorders
- THALLIUM POISONING
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- The pathophysiology of delayed ejaculation
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- An Update on Drug-Induced Pigmentation
- Secondary cicatricial and other permanent alopecias
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy
- ADVANCES IN PSORIASIS THERAPY
- Topical use of systemic drugs in dermatology: A comprehensive review
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Phenolsulphotransferase: localization in kidney during human embryonic and fetal development
- PROTECTION AGAINST CYTOSINE ARABINOSIDE-INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Developing a Framework for Sources of New Product Ideas
- AROMA THERAPY: AN ART OF HEALING
- Exosomes as a novel pathway for regulating development and diseases of the skin (Review)
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- External post mortem artefact: a key issue in hair result interpretation
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy